open access

Vol 13, No 1 (2018)
Review of Literature
Published online: 2018-03-23
Get Citation

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers — a meta-analysis of 38 randomized studies on impact of renin–angiotensin–aldosterone inhibitors on cardiovascular risk in patients with heart failure

Maciej Krzysztof Kluk
DOI: 10.5603/C.2018.0019
·
Folia Cardiologica 2018;13(1):104-106.

open access

Vol 13, No 1 (2018)
Review of Literature
Published online: 2018-03-23

Abstract

W aktualnym podsumowaniu piśmiennictwa zaprezentowano metaanalizę badań randomizowanych na temat znaczenia rokowniczego leków hamujących układ renina-angiotensyna-aldosteron w pacjentów z niewydolnością serca.

Abstract

W aktualnym podsumowaniu piśmiennictwa zaprezentowano metaanalizę badań randomizowanych na temat znaczenia rokowniczego leków hamujących układ renina-angiotensyna-aldosteron w pacjentów z niewydolnością serca.
Get Citation

Keywords

cardiovascular risk, heart failure, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers

About this article
Title

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers — a meta-analysis of 38 randomized studies on impact of renin–angiotensin–aldosterone inhibitors on cardiovascular risk in patients with heart failure

Journal

Folia Cardiologica

Issue

Vol 13, No 1 (2018)

Pages

104-106

Published online

2018-03-23

DOI

10.5603/C.2018.0019

Bibliographic record

Folia Cardiologica 2018;13(1):104-106.

Keywords

cardiovascular risk
heart failure
angiotensin-converting enzyme inhibitors
angiotensin II receptor blockers

Authors

Maciej Krzysztof Kluk

References (1)
  1. Tai C, Gan T, Zou L, et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2017; 17(1): 257.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl